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Sirtuins (SIRT1-7) have attracted considerable atten-
tion as regulators of metabolism over the past
decade. However, the physiological functions and
molecular mechanisms of SIRT7 are poorly under-
stood. Here we demonstrate that Sirt7 knockout
mice were resistant to high-fat diet-induced fatty
liver, obesity, and glucose intolerance, and that he-
patic triglyceride accumulation was also attenuated
in liver-specific Sirt7 knockout mice. Hepatic SIRT7
positively regulated the protein level of TR4/TAK1,
a nuclear receptor involved in lipid metabolism, and
as a consequence activated TR4 target genes to in-
crease fatty acid uptake and triglyceride synthesis/
storage. Biochemical studies revealed that the
DDB1-CUL4-associated factor 1 (DCAF1)/damage-
specific DNA binding protein 1 (DDB1)/cullin 4B
(CUL4B) E3 ubiquitin ligase complex interacted with
TR4, leading to its degradation, while binding of
SIRT7 to theDCAF1/DDB1/CUL4B complex inhibited
the degradation of TR4. In conclusion, we propose
that hepatic SIRT7 controls lipid metabolism in liver
by regulating the ubiquitin-proteasome pathway.
INTRODUCTION
Sirtuins are evolutionally conserved enzymes, which are nico-
tinamide adenine dinucleotide (NAD+)-dependent histone de-712 Cell Metabolism 19, 712–721, April 1, 2014 ª2014 Elsevier Inc.acetylases that regulate a wide variety of biological functions
(Houtkooper et al., 2012). There are seven mammalian sirtuins
(SIRT1-7) with different subcellular localizations, catalytic activ-
ities, and functions. SIRT7 was initially reported to be a positive
regulator of the transcription of RNA polymerase I (Ford et al.,
2006). More recently, SIRT7 was also identified as a NAD+-
dependent deacetylase with a high selectivity for the acetylated
lysine 18 of histone H3 (H3K18Ac) (Barber et al., 2012). However,
the role of SIRT7 in metabolism remains unknown.
In the present study, we demonstrate that Sirt7 knockout (KO)
mice were resistant to hepatic steatosis induced by a high-fat
diet (HFD) and that SIRT7 controls lipid metabolism in liver by
regulating the ubiquitin-proteasome pathway.RESULTS
Sirt7 KO Mice Are Resistant to HFD-Induced Hepatic
Steatosis
SIRT1, SIRT3, and SIRT6 play a critical role in metabolism, and
loss of these sirtuins in mice results in hepatic accumulation of
lipids (Houtkooper et al., 2012). Therefore, we examined whether
loss of SIRT7 had any effect on lipid metabolism in mice. In strik-
ing contrast to Sirt1, Sirt3, and Sirt6 KO mice, Sirt7 KO mice fed
a HFD for 22 weeks showed less accumulation of hepatic lipid
droplets than wild-type (WT) controls on histological analysis
(Figure 1A). Consistent with this finding, the hepatic triglyceride
(TG) content was significantly lower in Sirt7 KOmice (Figure 1B).
TG content was similar in Sirt7 KO mice and WT littermates fed
normal chow (NC) (Figure 1B). Less hepatic TG and cholesterol
accumulation was also seen in Sirt7 KO mice fed a HFD for
shorter periods (Figure 1C; Figure S1A available online), and
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SIRT7 Controls Lipid Metabolism via TR4 Turnoverthe lipid droplet area was smaller in Sirt7 KO mice (Figures 1D
and 1E). Hepatic expression of other sirtuin genes was un-
changed in Sirt7 KO mice fed a HFD (Figure S1B). The weight
of the liver was significantly reduced in Sirt7 KO mice fed a
HFD (Figure S1C). Consistent with the decreased hepatic lipid
accumulation, the serum level of alanine aminotransferase
(ALT) was significantly lower in Sirt7 KO mice (Figure 1F). There
was no significant difference of TG accumulation in the gastroc-
nemius muscle (Figure 1G). Serum levels of TG and cholesterol
did not differ significantly between Sirt7 KO mice and controls
(data not shown).
We analyzed the expression of genes involved in lipid meta-
bolism in the livers of HFD-fed WT and Sirt7 KO mice. Cd36
plays a crucial role in fatty acid uptake (Koonen et al., 2007),
and it showed significantly lower expression in Sirt7 KO mice
(Figure 1H). Among the genes involved in TG synthesis and
storage, expression of the gene encoding monoacylglycerol
O-acyltransferase 1 (Mogat1), which is involved in the incorpora-
tion of fatty acids into TG, was significantly decreased inSirt7KO
mice, as was the expression of cell-death-inducing DFFA-like
effector a (Cidea) and cell-death-inducing DFFA-like effector c
(Cidec) (Figure 1I). Both CIDEA and CIDEC play an important
role in lipid storage, lipid droplet formation, and lipolysis, and
it has been reported that knockdown (KD) of Cidec in ob/ob
mice results in the loss of hepatic lipid accumulation (Matsusue
et al., 2008). Decreased expression of genes related to lipo-
genesis was also observed in Sirt7 KO mice (Figure S1D).
Furthermore, hepatic expression of several genes involved in
b-oxidation was lower in Sirt7 KO mice than in WT controls
(Figure S1E). As shown in Figure S1F, the secretion rate of
very-low-density lipoprotein (VLDL)-TG was similar in WT and
Sirt7 KO mice fed a HFD.
We further elucidated the role of SIRT7 in hepatocytes using
liver-specific conditional Sirt7 KO (Sirt7 LCKO) mice (Fig-
ure S1G). Deletion of Sirt7 gene was restricted to the liver (Fig-
ure S1H). As shown in Figure 1J, hepatic TG accumulation
was significantly decreased in Sirt7 LCKO mice than in control
mice after HFD feeding. This result was supported by the histo-
logical finding that Sirt7 LCKO mice had fewer hepatic lipid
droplets, especially around Glisson’s sheath, than control mice
(Figure 1K).
Sirt7 KO Mice Are Resistant to HFD-Induced Obesity
and Glucose Intolerance
In addition to the decrease of hepatic lipid accumulation, there
was significant attenuation of weight gain and a decrease ofFigure 1. Sirt7 KO Mice Are Resistant to HFD-Induced Hepatic Steatos
(A) Representative HE-stained sections of livers from WT and Sirt7 KO mice fed
(B and C) Hepatic TG content in WT and Sirt7 KO mice.
(D and E) Lipid droplet area in livers fromWT and Sirt7 KOmice. The ratio of the ar
which was defined as the area except for the blood vessels in the region with a wi
example is shown in (E). Blood vessels are shown in red and lipid droplets are ye
(F) Serum ALT levels in WT and Sirt7 KO mice.
(G) TG content in gastrocnemius (GC) muscles from WT and Sirt7 KO mice.
(H and I) Hepatic gene expression patterns in WT and Sirt7 KO mice (HFD for 12
(J) Hepatic TG content in Sirt7 LCKO mice and controls.
(K) Representative Sudan-Black-stained sections of livers from Sirt7 LCKOmice a
means ±SEM. *p < 0.05. See also Figure S1.
714 Cell Metabolism 19, 712–721, April 1, 2014 ª2014 Elsevier Inc.epididymal white adipose tissue (WAT) in Sirt7 KO mice after
HFD feeding (Figures 2A and 2B). Consistent with the decrease
of WAT, Sirt7 KO mice showed a 69% reduction of the serum
leptin level compared with WT mice (Figure S2A). Reduced
expression of Cd36 and Cidea was also observed in the WAT
of Sirt7 KO mice fed a HFD (Figure S2B). Likewise, decreased
expression of genes related to inflammation occurred in the
WAT of Sirt7 KO mice (Figure S2C). Fasting blood glucose and
insulin levels were both significantly lower in Sirt7 KO mice
compared with WT controls (Figures 2C and 2D). The glucose
tolerance test (GTT) demonstrated better glucose tolerance of
Sirt7 KO mice compared with WT controls (Figures 2E and
S2D). In contrast, body weight, WAT weight, and glucose toler-
ance were similar between Sirt7 LCKO and control mice (Figures
S2E–S2G). These findings suggest that SIRT7 in nonhepatic
tissues has a major influence on body weight and glucose toler-
ance. The insulin tolerance test (ITT) revealed significantly better
insulin tolerance of Sirt7 KO mice (Figures 2F and S2D). Hepatic
expression of glucose-6-phosphatase (G6pc) and pyruvate
dehydrogenase kinase 4 (Pdk4) was reduced in Sirt7 KO mice
(Figure S2H). The results of the pyruvate tolerance test (PTT)
suggested the suppression of gluconeogenesis in Sirt7 KO
mice receiving a HFD (Figures 2G and S2D). We next performed
a hyperinsulinemic-euglycemic clamp study. Both the glucose
infusion rate and the whole-body glucose disposal rate were
significantly increased, while clamp endogenous glucose pro-
duction was significantly reduced, in Sirt7 KO mice (Figure 2H).
In addition, the percent decrease of endogenous glucose pro-
duction from the basal to clamp state was significantly larger
in Sirt7 KO mice. These results confirm that insulin sensitivity is
improved in Sirt7 KO mice receiving a HFD.
Locomotor activity and food intake were unchanged in Sirt7
KOmice fed a HFD (Figure S2I). Therefore, wemeasured oxygen
consumption (VO2) and carbon dioxide production (VCO2) rates
in WT and Sirt7 KO mice. Although VO2 did not differ between
the two groups, the respiratory exchange ratio (RER), which
reflects the relative amount of energy derived from carbo-
hydrates versus lipids, was significantly decreased in Sirt7 KO
mice, especially during the dark period (Figures 2I and 2J). These
results suggest that Sirt7 KOmice receiving a HFD preferentially
employed fat for energy production.
With regard to energy metabolism, the body temperature of
Sirt7 KO mice fed a HFD was significantly higher than that of
WT mice (Figure 2K). Because brown adipose tissue (BAT) plays
a central role in controlling energy expenditure through thermo-
genesis, we investigated BAT in Sirt7 KO mice. Intake of a HFDis
a HFD for 22 weeks.
ea occupied by lipid droplets (D) was calculated relative to the total tissue area,
dth of 100 mm from Glisson’s sheath ‘‘G’’ to central vein ‘‘CV.’’ A representative
llow. p values were calculated by Mann-Whitney test.
weeks).
nd controls. Albumin-Cre littermates were used as controls. Data are shown as
A B C D
E F G
H I
J K L
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SIRT7 Controls Lipid Metabolism via TR4 Turnoverleads to adipocyte hypertrophy and an increase of BAT mass.
BATweight was significantly reduced inSirt7KOmice compared
with WT controls (Figure S2J). Expression of the genes encoding
uncoupling protein 1 (Ucp1) and deiodinase, iodothyronine, type
II (Dio2), which are involved in thermogenesis, was significantly
increased in Sirt7 KO mice (Figure 2L). These findings suggest
that SIRT7may regulate whole-body energymetabolism, at least
partly through regulating BAT function.
SIRT7 Regulates TR4 Expression
Cd36 mRNA expression was unchanged in the muscles of Sirt7
KO mice fed a HFD (Figure S3A). To address the role of SIRT7 in
hepatic gene regulation, we examined gene expression in liver
parenchymal cells (PC) purified from NC-fed WT and Sirt7 KO
mice. The expression of Cd36, Cidea, andMogat1 was reduced
in liver PC purified fromSirt7KOmice (Figure 3A). In contrast, the
expression of genes related to lipogenesis (Fasn, Me1, Elovl6,
and Acaca) was unchanged (Figure 3A), suggesting that the al-
terations of these genes in vivo represented a secondary effect.
Expression of Cd36, Cidea, Cidec, and Mogat1 was decreased
in primary cultured hepatocytes (pHepatocytes) obtained from
NC-fed Sirt7 KO mice (Figure S3B). We found that expression
of both Cd36 and Cidec was significantly decreased in several
types of cells with Sirt7 KD (Figures 3B, S3C, and S3D), demon-
strating that hepatic SIRT7 regulates the expression of these
genes via a cell-autonomous mechanism.
The lipid accumulation test demonstrated that lipid droplets
were markedly reduced in Sirt7 KD cells cultured in the presence
of free fatty acids (FFAs) (Figures 3C and 3D), indicating that
hepatic SIRT7 indeed controls TG accumulation. There was no
difference of lipid accumulation when cells transfected with con-
trol and Sirt7 siRNA were cultured in complete medium without
FFAs (Figure 3D), consistent with our observations in NC-fed
Sirt7 KO mice (Figure 1B). In agreement with the decrease of
Cd36 expression, fatty acid uptake by Sirt7 KD AML-12 cells
was significantly lower than that by control cells (Figure 3E).
SIRT7 is an H3K18Ac deacetylase (Barber et al., 2012). To
investigate how SIRT7 regulates the hepatic gene expression,
we examined the H3K18Ac status in the livers of Sirt7 KO
mice. We found that the H3K18Ac level did not differ between
WT and Sirt7 KO mice (Figure S3E). Expression of 45S pre-
ribosomal RNA (pre-rRNA) and ribosomal protein S20 (Rps20),
which are reported to be genes regulated by SIRT7, was also
unchanged in the livers of Sirt7 KO mice (Figure S3F).
It has been reported that nuclear receptor TR4/TAK1 plays a
critical role in the regulation of lipid homeostasis (Kang et al.,
2011). Noticeably, Tr4 KO mice are resistant to HFD-induced
hepatic steatosis, and show highly similar changes of geneFigure 2. Sirt7 KO Mice Are Resistant to HFD-Induced Obesity and Glu
(A) Growth curves of WT and Sirt7 KO mice receiving a HFD.
(B) Percent epididymal (Epi.) WAT weight calculated relative to body weight in W
(C) Blood glucose levels in WT and Sirt7 KO mice (HFD for 9–10 weeks).
(D) Fasting serum insulin levels in WT and Sirt7 KO mice (HFD for 12 weeks).
(E–G) Results of the GTT (E), ITT (F), and PTT (G) in WT and Sirt7 KO mice (HFD
(H) Hyperinsulinemic-euglycemic clamp study. Glucose infusion rate (GIR), endo
change of EGP (DEGP), and glucose disposal rate in WT and Sirt7 KO mice (HFD
(I–K) Data on the energy balance. RER (I), VO2 and VCO2 (J), and body temperat
(L) Gene expression in the BAT of fasted WT and Sirt7 KO mice (HFD for 14 wee
716 Cell Metabolism 19, 712–721, April 1, 2014 ª2014 Elsevier Inc.expression pattern to Sirt7 KO mice (compare Figure S3G with
Figure 2C of Kang et al., 2011). Therefore, we assessed the
hepatic level of TR4 protein in NC-fed Sirt7 KO mice by western
blot analysis, which revealed that, indeed, TR4 was decreased in
Sirt7 KO mice (Figure 3F). Expression of PPARg, a transcription
factor regulated by TR4, was also reduced in Sirt7 KO mice. In
contrast, the expression of other nuclear factors was unchanged
(Figure 3F). A decrease of TR4 expression was not observed in
other organs of Sirt7 KO mice (Figure S3H). In addition, KD of
Sirt7 in AML-12 cells and Hepa1-6 cells led to a marked reduc-
tion of TR4 expression (Figures 3G), while the overexpression
of WT-SIRT7 restored TR4 expression in Sirt7 KD AML-12 cells
(Figure 3H). The histidine residue at position 188 (H188) and
serine residue at position 112 (S112) are highly conserved resi-
dues among sirtuins, and H188 is reported to be important
for binding with NAD+ (Finnin et al., 2001). The rescue of TR4
expression was abolished by mutation of conserved residues
that inactivated Sirt7 (Sirt7S112A, Sirt7H188Y, and Sirt7S112A/H188Y)
(Ford et al., 2006) (Figure 3H), suggesting that NAD+-dependent
enzymatic activity of SIRT7 is required for the regulation of TR4.
As shown in Figures 3I and 3J, the decrease of lipid accumulation
and Cd36 expression in Sirt7 KO mice returned to control levels
after infection with a TR4-expressing adenovirus (Tr4-Ad). In
addition, TR4 overexpression was associated with an increase
of lipid accumulation in Sirt7 KD AML-12 cells (Figures 3K, S3I,
and S3J). Thus, these results suggest that hepatic SIRT7 con-
trols lipid accumulation in hepatocytes, at least partly in a TR4-
dependent manner.
SIRT7 Binds to the DCAF1/DDB1/CUL4B Complex
and Inhibits Degradation of TR4
Expression of Tr4 mRNA was unchanged in the livers of Sirt7
KO mice and in Sirt7 KD AML-12 cells (Figures 4A and S4A).
Therefore, we examined the influence of SIRT7 on the stability
of TR4 protein by pulse-chase experiments. As shown in Figures
4B and S4B, TR4wasmore rapidly degraded in Sirt7KDAML-12
cells. To investigate whether the ubiquitin-proteasome pathway
is responsible for degradation of TR4 and whether SIRT7 plays a
role in this pathway, we performed a TR4 ubiquitination assay.
Ubiquitination of TR4 was clearly detected in the cells tested,
and transfection of Sirt7 expression vector markedly reduced
TR4 ubiquitination (Figure 4C). In contrast, the global ubiquitina-
tion status was not altered in the Sirt7 KO liver (Figure S4C),
demonstrating that SIRT7 regulates the level of TR4 protein by
selectively inhibiting its ubiquitination.
SIRT1 has been reported to interact with LXR, promoting its
deacetylation and subsequent ubiquitination (Li et al., 2007), so
it was possible that SIRT7 had an influence on the stability ofcose Intolerance
T and Sirt7 KO mice (HFD for 12 weeks).
for 10–11 weeks).
genous glucose production during the clamped state (clamped EGP), percent
for 13 weeks).
ure (K) over 2 days in WT and Sirt7 KO mice (HFD for 13 weeks).
ks). Data are shown as means ±SEM. *p < 0.05. See also Figure S2.
A B
C D E
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Figure 3. SIRT7 Regulates TR4 Expression, which Is Important for Lipid Homeostasis
(A and B) Gene expression in purified liver parenchymal cells ‘‘PC’’ (A), and AML-12 cells transfected with the indicated siRNA (B). PC were obtained fromWT and
Sirt7 KO mice fed NC. ‘‘ND’’ means ‘‘not detectable.’’
(legend continued on next page)
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SIRT7 Controls Lipid Metabolism via TR4 TurnoverTR4 protein by a similar mechanism. However, we failed to
detect any interaction between SIRT7 and TR4 in a coimmuno-
precipitation assay (Figure S4D), GST pull-down assay, and
mammalian two-hybrid assay (data not shown), suggesting
that SIRT7 regulates TR4 protein stability in a different way
from that reported for SIRT1 and LXR.
Subsequently, we systematically searched for molecules
interacting with TR4 by performing affinity chromatography
(HaloTag pull-down assay) of mouse liver nuclear extract, fol-
lowed by liquid chromatography-tandem mass spectrometry
(LC-MS/MS) analysis. Interestingly, we detected DCAF1 and
DDB1, which are components of a CUL4 E3 ubiquitin ligase
complex (Lee and Zhou, 2007), as proteins interacting with
TR4 (Figure S4E). Interaction of DCAF1 and DDB1 with TR4
was detected by the coimmunoprecipitation assay, and the
interaction was markedly augmented in the presence of a 26S
proteasome inhibitor MG132 (Figures 4D and 4E). TR4 was
also found to associate with CUL4B E3 ubiquitin ligase (Fig-
ure S4F), indicating that the DCAF1/DDB1/CUL4B E3 ubiquitin
ligase complex interacts with TR4.
Since SIRT7 inhibits the ubiquitination of TR4 (Figure 4C) and
hepatic cells show high expression of SIRT7, we suspected that
activity of DCAF1/DDB1/CUL4B E3 ubiquitin ligase complex
in hepatic cells might be suppressed by SIRT7. Therefore, we
examined the effect of Cul4b siRNA on TR4 protein expression
under Sirt7 KD conditions. As expected, suppression of Cul4b
by siRNA in Sirt7 KD Hepa1-6 cells led to a marked increase
of TR4 protein (Figure 4F). These results suggest that the
DCAF1/DDB1/CUL4B E3 ubiquitin ligase complex interacts
with TR4 to promote its ubiquitination and degradation in
hepatocytes.
We next examined whether SIRT7 binds to the DCAF1/DDB1/
CUL4B complex. We found that SIRT7 bound strongly to
DCAF1, DDB1, and CUL4B without MG132 in COS-7 cells (Fig-
ures 4G, 4H, and S4G). Binding of SIRT7 to DCAF1 was also
confirmed in AML-12 cells (Figure S4H). Since we could not
detect any interaction of SIRT7 with TR4, these results imply
that SIRT7 binds to the DCAF1/DDB1/CUL4B complex in the
absence of TR4. Additionally, SIRT7 mutants, the overexpres-
sion of which failed to restore TR4 expression in Sirt7 KD
AML-12 cells, showed binding to DCAF1, DDB1, and CUL4B
(Figures 4G, 4H, and S4G). This suggested that enzymatic acti-
vity of SIRT7 is not required for binding to the complex. Next,
we investigated whether SIRT7 regulates DCAF1/DDB1/
CUL4B complex-dependent degradation of TR4. As shown in
Figure 4I, the level of TR4 protein was decreased by transfection(C and D) Lipid accumulation test in AML-12 cells transfected with indicated siRN
staining (D). Relative staining was calculated by comparison with the staining of
medium without FFA).
(E) Relative BODIPY FL C16 uptake over a 15 min period in AML-12 cells transfe
(F) Nuclear transcription factor protein levels in the livers of 15-week-old WT and
(G) TR4 protein levels in AML-12 cells and Hepa1-6 cells transfected with the ind
(H) TR4 protein levels in AML-12 cells transfected with the indicated siRNA and va
‘‘wild-type Sirt7’’; ‘‘S112A,’’ ‘‘H188Y,’’ and ‘‘S112A/H188Y’’ indicate mutant form
relative amounts of bands after normalization with the loading control.
(I and J) Hepatic TG content (G) and relative Cd36 gene expression (H) in mice
Procedures.
(K) Lipid accumulation test in recombinant adenovirus-infected AML-12 cells. See
Figure S3.
718 Cell Metabolism 19, 712–721, April 1, 2014 ª2014 Elsevier Inc.of Hepa1-6 cells with Sirt7 siRNA, but reduction of TR4 was not
observed in Cul4b KD cells. The overexpression of WT-SIRT7
increased TR4 expression in Sirt7 KD AML-12 cells. But, this
effect on TR4 expression was abolished by concomitant Cul4b
KD (Figure S4I). These results indicate that SIRT7 binds to the
DCAF1/DDB1/CUL4B complex, thereby inhibiting the ubiquiti-
nation and degradation of TR4.
Finally, we investigated whether SIRT7 causes deacetylation
of DCAF1, DDB1, or CUL4B. It has been reported that nicotin-
amide (NAM) treatment strongly induces PGC-1a lysine acetyla-
tion, while SIRT1 causes deacetylation of PGC-1a in 293T cells
(Rodgers et al., 2005). Although acetylation of PGC-1a was
clearly observed, we could not detect acetylated DCAF1/
DDB1/CUL4B proteins under the same experimental conditions
(Figures S4J–S4N). Thus, further studies will be necessary to
clarify the role of SIRT7 in the acetylation (or other modifications)
of the ubiquitin ligase complex.
DISCUSSION
Previous reports have indicated that SIRT1, SIRT3, and SIRT6
promote lipid utilization in the liver (Houtkooper et al., 2012).
SIRT7 apparently plays an opposite role in hepatic lipid homeo-
stasis. Our results demonstrated that hepatic SIRT7 activates
the expression of genes involved in fatty acid uptake (Cd36)
and TG synthesis (Mogat)/storage (Cidea, Cidec). Expression
of these genes was reduced in Sirt7 KO mice fed NC, while lipid
accumulation was unchanged. Decreased expression of these
genes and unchanged lipid accumulation were also seen in
Sirt7 KD cells cultured without FFA (Figures 3B and 3D).
Increased dietary availability of FFAs by HFD might contribute
to the phenotype of Sirt7 KO mice fed a HFD.
In addition, we demonstrate that deficiency of SIRT7 has a
protective effect against HFD-induced obesity. CD36 has previ-
ously been reported to have a role in fatty acid uptake by adipose
tissue (Coburn et al., 2000), and depletion of CIDEA from human
adipocytes by siRNA stimulates lipolysis (Nordstro¨m et al., 2005).
Decreased expression of Cd36 and Cidea in WAT (Figure S2B)
might be involved in the reduction of WAT weight in HFD-fed
Sirt7 KO mice. WAT-associated inflammation plays a critical
role in the development of obesity; accordingly, the expression
of genes related to inflammation was significantly decreased
in Sirt7 KO mice (Figure S2C). We also found an increase of
thermogenesis in Sirt7 KOmice along with increased expression
of Ucp1 and Dio2 in BAT (Figures 2K and 2L). Thus, SIRT7 regu-
lates lipid metabolism in adipocytes as well as in the liver.A. Representative example of oil red O staining (C). Relative level of Oil Red O
control siRNA-transfected AML-12 cells cultured in normal medium (complete
cted with indicated siRNA.
Sirt7 KO mice fed NC.
icated siRNA.
rious Sirt7 expression vectors (‘‘empty’’ denotes ‘‘empty vector’’; ‘‘WT’’ means
s of Sirt7). ‘‘Con.’’ is ‘‘control.’’ Numbers on the TR4 western blots show the
infected with the indicated adenovirus (Ad). See Supplemental Experimental
also Figures S3I and S3J. Data are shown as means ±SEM. *p < 0.05. See also
A B C
D E F
G H
I J
Figure 4. SIRT7 Binds to the DCAF1/DDB1/CUL4B Complex and Inhibits Degradation of TR4
(A) Levels of TR4 mRNA in AML-12 cells transfected with the indicated siRNA.
(B) Time course of the decay of Halo-TR4 in the pulse-chase experiment. AML-12 cells were transfectedwith combinations of pFN21A-TR4 (for Halo-TR4) and the
indicated siRNA. Half-life of TR4 protein (right panel) was calculated from time course graph.
(C) TR4 ubiquitination assay in COS-7 cells transfected with the Sirt7 expression vector or empty vector.
(D and E) Coimmunoprecipitation assay detecting the interaction between FLAG-TR4 and the indicated proteins in COS-7 cells incubated with or withoutMG132.
(legend continued on next page)
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SIRT7 Controls Lipid Metabolism via TR4 TurnoverFurthermore, we identified a role of SIRT7 as a regulator of
protein turnover. SIRT7 binds to the DCAF1/DDB1/CUL4B E3
ubiquitin ligase complex and inhibits the ubiquitination of TR4,
thereby preventing its degradation. Subsequently, TR4 directly
and/or indirectly regulates the expression of genes related to
fatty acid uptake and TG synthesis/storage (Kang et al., 2011)
and consequently controls hepatic lipid accumulation (Figure 4J).
To our knowledge, direct binding of a sirtuin to a ubiquitin ligase
complex and regulation of its function has not bee reported.
Enzymatic activity of SIRT7 seems to be required to inhibit the
ubiquitin ligase complex (Figure 3H). However, due to the
absence of acetylated DCAF1/DDB1/CUL4B proteins in NAM-
treated 293T cells, we could not further examine the effect of
SIRT7 on these proteins. Expression of acetyltransferases for
these proteins may be low in 293T cells. Alternatively, other pro-
teins in the DCAF1/DDB1/CUL4B E3 ubiquitin ligase complex
may be direct targets of SIRT7. Further studies will be necessary
to address how SIRT7 inhibits the function of this complex.
During the revision of this manuscript, Shin et al. (2013) re-
ported another line of Sirt7 KO mice. Both their Sirt7 KO mice
fed NC and our mutant mice fed a HFD were leaner than the
controls (Figure 2A). However, their SIRT7-deficient mice fed
NC developed fatty liver at 4–6 months. They also reported
that liver-specific reconstitution of SIRT7 in Sirt7 KO mice
reversed the fatty liver phenotype. In contrast, our 22-week-old
Sirt7 KO mice fed NC did not develop fatty liver, and 12-week-
old Sirt7 KOmice were resistant to HFD-induced hepatic steato-
sis. Thus, the observed phenotypes were far more different than
explained by the difference in experimental protocol. At this
point, we have no adequate explanation for these contrasting
findings, but the decreased hepatic lipid accumulation in our
Sirt7 KO mice was further validated in Sirt7 LCKO mice and
Sirt7 KD cells. Prevention of steatosis in Sirt7 KO mice on a
HFD has also been independently verified (E. Bober, personal
communication). Based on the targeting construct used by
Shin et al. (2013), production of an N-terminal SIRT7-b-galacto-
sidase fusion protein is predicted. Different constructs (absence
of LacZ in our mice) or background strains of mice (C57BL/6
for our studies versus a 129Sv-related background for Shin
et al., 2013) may have contributed to the different results of the
two studies.
In conclusion, we clarified a metabolic role of SIRT7. Our find-
ings suggest that specific SIRT7 inhibitors could be beneficial
for the treatment of metabolic disorders, such as hepatic steato-
sis. However, further studies will be necessary to improve our
understanding of SIRT7 as a therapeutic target.EXPERIMENTAL PROCEDURES
Mice
These experiments were conducted according to the guidelines of the Institu-
tional Animal Committee of Kumamoto University. Sirt7 KOmice (Vakhrusheva(F) TR4 protein level in Sirt7 KD Hepa1-6 cells transfected with the indicated siR
(G, H) Coimmunoprecipitation of various FLAG-SIRT7 and the indicated proteins
(I) TR4 protein expression in Hepa1-6 cells transfected with the indicated siRNA co
the loading control.
(J) Proposed model for regulation of TR4-dependent hepatic lipid metabolism by
‘‘WB’’ denotes ‘‘western blotting.’’ ‘‘IP’’ means ‘‘immunoprecipitation.’’ Data are
720 Cell Metabolism 19, 712–721, April 1, 2014 ª2014 Elsevier Inc.et al., 2008) were backcrossed for five generations with C57/BL6J (CLEA
Japan Inc.). Generation of Sirt7 LCKO mice is described in the Supplemental
Experimental Procedures. For HFD experiments, 6-week-old male mice
were fed a HFD (HFD-60; Oriental Yeast Co., Ltd.; Tokyo) ad libitum for the
indicated times.
Histological Studies
Animals were deeply anesthetized with sodium pentobarbital (100 mg/kg,
intraperitoneally) and were perfused through the ascending aorta with 0.1 M
phosphate-buffered saline (PBS [pH 7.4]), followed by 25 ml of 2.5% glutaral-
dehyde and 2% paraformaldehyde in 0.1 M phosphate buffer (PB) (pH 7.4) at
room temperature. Blocks of liver tissue were postfixed with 1% osmium
tetroxide in PB for 2 hr, stained en-bloc with 1.5% uranyl acetate, and
embedded in Araldite (TAAB). Serial sections (0.5 mm thick) were cut on an
ultramicrotome (UC7b, Leica), mounted on slides, and stained with toluidine
blue or Sudan Black.
Gene Expression Studies
Total RNA was extracted by using Sepasol RNA I super reagent (Nacalai
Tesque; Japan). qRT-PCR was performed with SYBR Premix Ex TaqII
(RR820A; TaKaRa; Japan) and an ABI 7300 thermal cycler (Applied Bio-
systems; California). Relative expression of each gene was normalized to
that of 18S rRNA, unless otherwise noted. The primer sequences are listed
in Table S1.
Metabolic Studies
Glucose (1.5 g/kg) or pyruvate (2 g/kg) was injected intraperitoneally after an
overnight fast for the GTT or PTT, respectively. For the ITT, insulin (0.6 U/kg)
was injected intraperitoneally after 3.5 hr of fasting.
Cell Culture
AML-12, Hepa1-6, and COS-7 cells were purchased from the American Type
Culture Collection, while 293T cells were obtained fromClontech. Culture con-
ditions are described in the Supplemental Experimental Procedures.
RNAi
For KD of Sirt7 and CUL4B, the following siRNAs were transfected with
HiPerfect transfection reagent (QIAGEN) according to the manufacturer’s
protocol: for control, AllStar Negative Control siRNA (QIAGEN); for Sirt7 siRNA,
FlexiTube siRNA Mm_Sirt7_5 (QIAGEN); for CUL4B siRNA-1, FlexiTube
siRNA Mm_CUL4B_3 (QIAGEN); and for CUL4B siRNA-2, FlexiTube siRNA
Mm_CUL4B_5 (QIAGEN). The conditions of experiments are described in
the Supplemental Experimental Procedures.
Lipid Accumulation Test in AML-12 Cells
AML-12 cells were cultured for 3 days after transfection in complete medium
and then cultured for a further 6 days in complete medium with or without
FFA (200 mM oleic acid bound to 0.2% defatted BSA). To detect lipid accu-
mulation, cells were stained with oil red O. Detailed information is described
in the Supplemental Experimental Procedures.
Western Blotting
Detailed information of primary antibodies and reaction conditions is
described in the Supplemental Experimental Procedures.
Preparation of Recombinant Adenovirus
Recombinant adenovirus was prepared by using an Adeno-X Expression
System 1 (Clontech Laboratories) according to the manufacturer’s protocol.NA.
in COS-7 cells.
mbination. Numbers show the relative amounts of bands after normalization by
SIRT7 through the ubiquitin-proteasome pathway. See Discussion for details.
shown as means ±SEM. *p < 0.05. See also Figure S4.
Cell Metabolism
SIRT7 Controls Lipid Metabolism via TR4 TurnoverHigh titer adenovirus was prepared with a Fast-Trap adenovirus purification
and concentration kit (EMD Millipore).
Immunoprecipitation Assays
COS-7 cells were transfected with the indicated expression plasmids using
JetPRIME transfection reagent (Polyplus, NY). After 24 hr, cells were lysed
and the lysates were subjected to immunoprecipitation with anti-FLAG
antibody beads or anti-HA antibody beads. Precipitates were examined
by western blotting with the indicated antibodies. Detailed information is
described in the Supplemental Experimental Procedures.
Statistical Analysis
All results are expressed as the mean ±SEM. Statistical significance was
tested using the two-tailed Student’s t test for comparison between two
groups, unless otherwise noted. For comparison of more than two groups,
one-way ANOVA was performed and Tukey’s multiple comparison test was
also used to assess the differences among individual groups. In all analyses,
p < 0.05 was considered to indicate a significant difference.
Miscellaneous
Further experimental procedures can be found in the Supplemental Experi-
mental Procedures.SUPPLEMENTAL INFORMATION
Supplemental Information includes four figures, one table, and Supplemental
Experimental Procedures and can be found with this article online at http://
dx.doi.org/10.1016/j.cmet.2014.03.006.
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